Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study

Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study

Objectives Immune checkpoint inhibitors (ICIs) are indicated for metastatic urothelial cancer (mUC), but predictive and prognostic factors are lacking. We investigated clinical variables associated with ICI outcomes.Methods We performed a multicentre retrospective cohort study of 135 patients who re...

Full description

Bibliographic Details
Main Authors: Rossanna C Pezo, April A N Rose, Cristiano Ferrario, Mengqi Li, Soumaya Labidi, Nicholas Meti, Reeta Barua, Jamila Riromar, Di Maria Jiang, Nazanin Fallah-Rad, Srikala S Sridhar, Sonia V Del Rincon, Susanna Cheng, Adrian G Sacher
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/3/e081480.full

Internet

https://bmjopen.bmj.com/content/14/3/e081480.full

Similar Items